Progress Halted: Congress Cuts Critical Funding for Gulf War Illness Research
For years, Gulf War Illness (GWI) veterans fought not only the debilitating effects of the disease but also the long battle for recognition. After more than three decades of advocacy and research, we were finally beginning to see real progress: new diagnostic codes, clearer understanding of mitochondrial dysfunction, and promising clinical trials.
Then Congress cut the funding in half.
A recent article from The War Horse, published in the Tucson Sentinel, lays out the troubling reality: after years of slow but steady advancement in understanding and treating Gulf War Illness, critical research funding has been slashed. The Congressionally Directed Medical Research Programs (CDMRP) toxic exposure research line, one of the few sources supporting high-risk, high-reward studies into GWI, was reduced from $30 million to $15 million in fiscal year 2025. That reduced level has remained in place for fiscal year 2026.
This 50% cut directly threatens ongoing work by leading researchers, including Dr. Beatrice Golomb at UC San Diego and Dr. Kimberly Sullivan at Boston University. Projects exploring mitochondrial dysfunction, biomarker development, and potential treatments like Coenzyme Q10 and n-acetylcysteine are now facing delays or uncertain futures.
Why This Matters
For many Gulf War veterans, this is not just about research budgets. It is about whether the suffering they have endured for 35 years will finally be addressed or simply prolonged.
As the article notes, an estimated 175,000 to 250,000 Gulf War veterans continue to live with the complex, multi-system symptoms of GWI. A new ICD-10 diagnostic code, effective October 1, 2025, finally gave clinicians and researchers a formal way to recognize and track the illness. That milestone, along with growing evidence pointing to mitochondrial impairment rather than only inflammation, represented hard-won progress.
Now, that momentum is at risk.
Veterans quoted in the piece, including Ron Brown and advocate Anthony Hardie, expressed the same frustration many of us feel: real scientific headway was finally being made, only to be undermined by short-sighted budget decisions.
Our Work at Battle Born GWI
At Battle Born GWI, we believe that veterans must be active partners in solving this problem, not passive subjects of research. That is why we are building a veteran-led coordination effort to connect Gulf War veterans with high-quality studies, support researchers who are doing the right work, and push for the sustained, adequate funding these efforts require.
The funding cuts described in this article make our mission even more urgent. Without consistent support for independent research, the progress we have fought so hard for could stall, or worse, reverse.
What You Can Do
We are calling on Gulf War veterans, their families, advocates, and allies to take action:
- Contact your members of Congress and urge them to restore and increase funding for GWI and toxic exposure research in the upcoming fiscal year.
- Share this story with fellow veterans and on social media.
- Stay engaged with Battle Born GWI as we continue building our network of veteran research partners and pushing for accountability.
The research community has shown that answers are possible. The question now is whether our elected leaders will give that research the support it needs, or continue to turn their backs on the veterans who served them.
Read the full article here: Vets with Gulf War Illness were finally seeing progress, but Congress cut funding.
We will not stop fighting for the recognition, research, and treatments our brothers and sisters deserve.
Battle Born. Still fighting.
Shawn George
Founder, Battle Born GWI Veterans Research Coordination